Guinea-Bissau vs Singapore: Previously treated cases tested for RR-/MDR-TB
Guinea-Bissau
54.0%
in 2024
Singapore
49.0%
in 2024
Guinea-Bissau rank
148th
Singapore rank
151st
Previously treated cases tested for RR-/MDR-TB over time
- Guinea-Bissau
- Singapore
How they compare
Guinea-Bissau currently reports 54.0% against 49.0% in Singapore, a difference of 5.0%.
That makes Guinea-Bissau's figure about 1.1 times Singapore's.
The two have swapped places 4 times across 11 shared years of data; in 2013 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 148th and Singapore ranks 151st of 180 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.6% | 71.7% | 18.1% | Singapore |
| 2020s | 62.2% | 74.8% | 12.5% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guinea-Bissau or Singapore?
- Guinea-Bissau, at 54.0% against 49.0% in Singapore as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guinea-Bissau and Singapore?
- 5.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Singapore?
- 11 years are reported by both, from 2013 to 2024.
- How do Guinea-Bissau and Singapore rank globally for previously treated cases tested for rr-/mdr-tb?
- Guinea-Bissau ranks 148th and Singapore ranks 151st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.